🔎 Trials Near Me

Home › Post-Traumatic Stress Disorder › California › San Francisco

Post-Traumatic Stress Disorder clinical trials in San Francisco, CA

5 studies for Post-Traumatic Stress Disorder are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Inflammatory Challenge and Fear

RecruitingPhase 1Healthy volunteers welcome
  • San Francisco VA Health Care System, San Francisco
Ages 18 to 65 · All sexes · Updated Sep 21, 2026 · NCT06630884

Brief Behavioral Treatment for Insomnia in Veterans With Posttraumatic Stress Disorder

RecruitingHealthy volunteers welcome
  • San Francisco VA Medical Center, San Francisco, CA, San Francisco
Ages 18 to 75 · All sexes · Updated Apr 21, 2026 · NCT05780177

Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD) (Seven Study)

RecruitingPhase 2
  • San Francisco VA Medical Center, San Francisco, CA, San Francisco
Ages 18 to 69 · All sexes · Updated Jan 29, 2026 · NCT04452500

Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress

RecruitingPhase 4
  • San Francisco VA Medical Center, San Francisco, CA, San Francisco
Ages 18 to 75 · All sexes · Updated Jul 18, 2025 · NCT03642028

A Comparative Effectiveness Study of PTSD Treatments Among Sexual and Gender Minority Populations

Recruiting
  • UCSF Alliance Health Project, San Francisco
Ages 18 and older · All sexes · Updated Apr 24, 2025 · NCT06367764

About Post-Traumatic Stress Disorder

 You can get Post-Traumatic Stress Disorder (PTSD) after experiencing a traumatic event. PTSD starts at different times for different people.

More about Post-Traumatic Stress Disorder on MedlinePlus

Post-Traumatic Stress Disorder trials in other cities

Other studies in San Francisco

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.